Parkinson's Disease Stocks List

Recent Signals

Date Stock Signal Type
2021-05-07 ACAD 20 DMA Support Bullish
2021-05-07 ACIU Lower Bollinger Band Walk Weakness
2021-05-07 ACIU NR7 Range Contraction
2021-05-07 ACIU Stochastic Buy Signal Bullish
2021-05-07 ADMS NR7 Range Contraction
2021-05-07 ADMS Narrow Range Bar Range Contraction
2021-05-07 ADMS 50 DMA Resistance Bearish
2021-05-07 AMRX 180 Bearish Setup Bearish Swing Setup
2021-05-07 AMRX MACD Bearish Signal Line Cross Bearish
2021-05-07 AMRX Wide Range Bar Range Expansion
2021-05-07 AMRX Fell Below 20 DMA Bearish
2021-05-07 ATHE NR7-2 Range Contraction
2021-05-07 ATHE Narrow Range Bar Range Contraction
2021-05-07 ATHE NR7 Range Contraction
2021-05-07 BCLI Narrow Range Bar Range Contraction
2021-05-07 BCLI Bollinger Band Squeeze Range Contraction
2021-05-07 CCM 180 Bearish Setup Bearish Swing Setup
2021-05-07 DNLI 200 DMA Resistance Bearish
2021-05-07 GMAB 200 DMA Support Bullish
2021-05-07 GMAB Stochastic Reached Overbought Strength
2021-05-07 IKT Crossed Above 20 DMA Bullish
2021-05-07 IKT Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-05-07 IKT MACD Bullish Signal Line Cross Bullish
2021-05-07 IKT 50 DMA Resistance Bearish
2021-05-07 IMPL NR7-2 Range Contraction
2021-05-07 IMPL NR7 Range Contraction
2021-05-07 NAVB Bollinger Band Squeeze Range Contraction
2021-05-07 NAVB 20 DMA Resistance Bearish
2021-05-07 NERV NR7 Range Contraction
2021-05-07 NERV Narrow Range Bar Range Contraction
2021-05-07 NERV Doji - Bullish? Reversal
2021-05-07 NERV Lower Bollinger Band Walk Weakness
2021-05-07 PRTA Crossed Above 50 DMA Bullish
2021-05-07 PRTA Crossed Above 20 DMA Bullish
2021-05-07 QURE NR7 Range Contraction
2021-05-07 QURE 20 DMA Resistance Bearish
2021-05-07 QURE 50 DMA Resistance Bearish
2021-05-07 TEVA 200 DMA Resistance Bearish
2021-05-07 VTVT Narrow Range Bar Range Contraction
2021-05-07 VYGR Spinning Top Other

Recent News for Parkinson's Disease Stocks

Date Stock Title
May 7 AMRX Amneal Pharmaceuticals, Inc. (AMRX) Q1 2021 Earnings Call Transcript
May 7 AMRX Amneal Pharmaceuticals, Inc. (AMRX) CEO Chintu Patel on Q1 2021 Results - Earnings Call Transcript
May 7 TEVA The Top 5 Trades of Francisco Garcia Parames' Firm
May 7 GMAB Genmab A/S (GMAB) Q1 2021 Earnings Call Transcript
May 7 AMRX Amneal Pharmaceuticals, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 7 GMAB Here’s Why Artisan Partners Reduced its Genmab A/S (GMAB) Position
May 7 ACAD The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of XL, VRM and ACAD
May 7 ACAD ACAD, FGEN, RMO INVESTOR ALERT: HAGENS BERMAN, National Trial Attorneys, Updates ACAD, FGEN, RMO Investors on Securities Class Actions and Application Deadlines, Encourages Investors with Losses to Contact the Firm
May 7 ACAD DEADLINE ALERT for FUV, EBS, ACAD, and CCIV: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
May 7 PRTA Puma (PBYI) Beats on Q1 Earnings, Ups Nerlynx Sales View
May 7 AMRX Amneal Pharmaceuticals (AMRX) Q1 Earnings Beat Estimates
May 7 AMRX Amneal Pharmaceuticals, Inc. to Host Earnings Call
May 7 TEVA Corcept Therapeutics Incorporated (CORT) Q1 2021 Earnings Call Transcript
May 7 AMRX Amneal Pharmaceuticals EPS beats by $0.02, misses on revenue
May 7 AMRX Amneal Reports First Quarter 2021 Financial Results
May 7 AMRX Earnings Scheduled For May 7, 2021
May 7 DNLI Bearish: Analysts Just Cut Their Denali Therapeutics Inc. (NASDAQ:DNLI) Revenue and EPS estimates
May 7 ACAD ACADIA Pharmaceuticals Inc. 2021 Q1 - Results - Earnings Call Presentation
May 6 ACAD HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Advises ACAD, FGEN, RMO Investors with Losses to Contact the Firm, Updates on Securities Class Actions and Application Deadlines
May 6 NTEC SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - NTEC, SNX, STAY, MX, MLND

Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system. The symptoms generally come on slowly over time. Early in the disease, the most obvious are shaking, rigidity, slowness of movement, and difficulty with walking. Thinking and behavioral problems may also occur. Dementia becomes common in the advanced stages of the disease. Depression and anxiety are also common, occurring in more than a third of people with PD. Other symptoms include sensory, sleep, and emotional problems. The main motor symptoms are collectively called "parkinsonism", or a "parkinsonian syndrome".The cause of Parkinson's disease is generally unknown, but believed to involve both genetic and environmental factors. Those with a family member affected are more likely to get the disease themselves. There is also an increased risk in people exposed to certain pesticides and among those who have had prior head injuries, while there is a reduced risk in tobacco smokers and those who drink coffee or tea. The motor symptoms of the disease result from the death of cells in the substantia nigra, a region of the midbrain. This results in not enough dopamine in these areas. The reason for this cell death is poorly understood, but involves the build-up of proteins into Lewy bodies in the neurons. Diagnosis of typical cases is mainly based on symptoms, with tests such as neuroimaging being used to rule out other diseases.There is no cure for Parkinson's disease, with treatment directed at improving symptoms. Initial treatment is typically with the antiparkinson medication levodopa (L-DOPA), with dopamine agonists being used once levodopa becomes less effective. As the disease progresses and neurons continue to be lost, these medications become less effective while at the same time they produce a complication marked by involuntary writhing movements. Diet and some forms of rehabilitation have shown some effectiveness at improving symptoms. Surgery to place microelectrodes for deep brain stimulation has been used to reduce motor symptoms in severe cases where drugs are ineffective. Evidence for treatments for the non-movement-related symptoms of PD, such as sleep disturbances and emotional problems, is less strong.In 2015, PD affected 6.2 million people and resulted in about 117,400 deaths globally. Parkinson's disease typically occurs in people over the age of 60, of which about one percent are affected. Males are more often affected than females at a ratio of around 3:2. When it is seen in people before the age of 50, it is called young-onset PD. The average life expectancy following diagnosis is between 7 and 14 years. The disease is named after the English doctor James Parkinson, who published the first detailed description in An Essay on the Shaking Palsy, in 1817. Public awareness campaigns include World Parkinson's Day (on the birthday of James Parkinson, 11 April) and the use of a red tulip as the symbol of the disease. People with Parkinson's who have increased the public's awareness of the condition include actor Michael J. Fox, Olympic cyclist Davis Phinney, and late professional boxer Muhammad Ali.

More about Parkinson's Disease
Browse All Tags